efavirenz and Lassitude

efavirenz has been researched along with Lassitude in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jianwei, L; Menghua, W; Qinwei, Y; Xin, Z; Yu, Z1
Ding, Y; Gao, M; He, N; Li, L; Lin, H; Liu, X; Shen, W; Wang, K; Wu, Q; Zhou, S1

Other Studies

2 other study(ies) available for efavirenz and Lassitude

ArticleYear
Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4
    AIDS research and therapy, 2020, 07-23, Volume: 17, Issue:1

    Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Betacoronavirus; C-Reactive Protein; CD4 Lymphocyte Count; Chills; Coronavirus Infections; COVID-19; Cyclopropanes; Fatigue; Female; Fever; HIV; HIV Infections; Humans; Immunocompromised Host; Immunoglobulin M; Lamivudine; Middle Aged; Pandemics; Pharyngitis; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sputum; Time Factors; Tomography, X-Ray Computed; Virus Shedding; Zidovudine

2020
Low body mass index and efavirenz use are independently associated with self-reported fatigue in HIV-infected patients.
    AIDS care, 2019, Volume: 31, Issue:4

    Topics: Adult; Age Factors; Alkynes; Anti-Retroviral Agents; Benzoxazines; Body Mass Index; CD4 Lymphocyte Count; China; Cyclopropanes; Fatigue; Female; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Self Report; Time Factors

2019